# Cardiol Therapeutics (CRDL) — Analyst Forecast

CRDL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crdl/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 6 | 0 | 0 | 6 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 23, 2026 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Aug 17, 2026 | Canaccord Genuity | Maintained | Buy | $10.00 |
| Jul 14, 2026 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Apr 6, 2026 | Canaccord Genuity | Maintained | Buy | $8.00 |
| Feb 10, 2026 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Dec 1, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Jun 2, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $9.00 |
| Apr 16, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Apr 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Feb 24, 2025 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Dec 18, 2024 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Nov 20, 2024 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Oct 24, 2024 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Jun 26, 2024 | Roth MKM | Initiated Coverage | Buy | $10.00 |
| Jun 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Jun 7, 2024 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| May 23, 2024 | Canaccord Genuity | Maintained | Buy | $8.00 |
| May 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $9.00 |
| Apr 22, 2024 | HC Wainwright & Co. | Initiated Coverage | Buy | $9.00 |
| Aug 14, 2023 | Cantor Fitzgerald | Maintained | Overweight | $3.00 |

## Frequently Asked Questions

### Is CRDL a buy, sell, or hold?

Analysts covering Cardiol Therapeutics currently average a Buy rating: 6 buy, 0 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on CRDL?

On Sep 23, 2026, HC Wainwright & Co. maintained Cardiol Therapeutics at Buy with a price target of $9.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).